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Introduction: Alternative modes of cardiopulmonary exercise testing are needed and arm cycling (AC) is
a promising alternative to the gold standard of leg cycling (LC). The aim of this study was to undertake
a systematic review comparing maximal oxygen consumption (VO2max) obtained from AC and LC in patient
populations with cardiovascular disease (CVD) and pulmonary disease (PD).Methods: A systematic review was
undertaken with literature searches on December 5, 2016. Studies were included if they directly compared
aerobic capacity values obtained fromAC and LC in patientswith CVD or PD. Results across studies were pooled
using random effects meta-analysis and univariate meta-regression were used to assess potential associations
between variables. Results: A total of 14 studies in 411 patients were included. On average, VO2max of LC
exceededACmean difference by 3.48mL·kg21·min21, (95% confidence interval [CI]: 1.94, 5.03) and ameanAC/
LC ratio of 0.83, (95% CI: 0.77, 0.90). VO2max differences between AC and LC were similar in patients with CVD
comparedwith PD butwere found to be higher in older individuals and thosewith higher VO2max. Conclusions:
AlthoughAQ:8 AC offers an important alternative form of exercise testing for patients with CVD or PD, clinicians
must take into account that VO2max values obtained from AC are consistently lower than those seem to LC.
However, the results of this article offer an evidence-based estimation for the proportional differences
between AC values and LC values for groups with CVD or groups with PD.AQ:9 (Cardiopulm Phys Ther J. 2018;00:
1–12) Key Words: cardiopulmonary exercise testing, arm cycle, leg cycle, cardiovascular disease, chronic
pulmonary disease, physical fitnessAQ:10
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INTRODUCTION
Cardiopulmonary exercise testing (CPET) is the
recommended noninvasive assessment of the physical
ﬁtness both in healthy populations as well as in the
context of rehabilitation in various patient groups,
including patients with cardiovascular disease (CVD)
and pulmonary disease (PD).1-5 When CPET is used in
rehabilitation, it typically has 3 purposes: an objective
measure of patients’ physical ﬁtness, a way of prescribing
exercise intensity, and a measure of intervention-speciﬁc
change over time.1-3
Cardiopulmonary exercise testing is traditionally
performed using lower limb exercise and often on a leg
cycle (LCAQ:11 ).5-8 However, patients with CVD and chronic
obstructive pulmonary disease (COPD) may be unable to
perform CPET on an LC due to lower limb comorbidities
such as peripheral vascular disease, neurological disease
among patients,9 or loss of muscle mass in the lower
limbs.10 Alternative modes of delivery such as CPET
performed using an arm cycle (ACAQ:12 ) are therefore needed.
A recently published systematic review and meta-
analysis in healthy adults reported a mean difference in
oxygen uptake of 12.5 mL·kg21·min21 favoring LC
compared with AC, and a linear relationship with a ratio
of 0.7 between the tests.11 This systematic review was
limited to studies on healthy adults and it is uncertain
whether the results are generalizable to patient popula-
tions.11 Although there may be equations to estimate LC
CPET values from AC obtained CPET values, these
equations are expected to have a large amount of error.
However, evidence within patient populations conﬁrms
the expected lower VO2max measurements during AC-
testing compared with LC-testing (eg, patients with
vascular surgery, COPD, orthotropic cardiac transplants,
and other CVD conditions), which can be explained by
the use of a smaller amount of muscle mass when
performing AC testing.9,12-14 In order for clinicians to use
AC values to prescribe the correct exercise training
intensity for patients with CVD or PD, the extent of the
difference between obtained maximum values from AC
and obtained maximum values from LC needs to be
clariﬁed.
The objective of this article is to undertake a systematic
review and a meta-analysis of studies directly comparing
aerobic capacity obtained from AC and LC in CVD and PD
patient populations and subsequently to establish a ratio
between AC and LC for use in everyday clinical practice.
METHOD
A protocol for this systematic review was published in
the International Prospective Register of Systematic
Reviews (PROSPERO—CRD42016048767),15 and the
reporting of the study was done according to the Preferred
Reporting Items for Systematic reviews and Meta-Analyses
(PRISMA) statement.16
Criteria for Considering Studies for This Review
Types of Studies. Randomized controlled trials, observa-
tional cohort studies, cross-sectional studies, and case-
control studies were considered eligible for inclusion.
Types of Cardiopulmonary Exercise Testing and Outcome
Measures. Studies directly comparing maximum or peak
oxygen uptake (VO2) values on AC and LC, preferably as
milliliter oxygen per kilogram per minute (mL·min21·kg2
1) or otherwise as liters per minute (L/min), were
considered eligible for inclusion. The VO2max values had
to be obtained from a nonassisted test (no external help, eg,
functional electrical stimulation or therapist-assisted
CPET), and patients had to perform both AC and LC
testing in a within-comparison design.
Types of Patients. The following patient groups were
included: Patients with CVD according to the World
Health Organization (WHO) deﬁnition, ie, coronary heart
disease, cerebrovascular disease, peripheral arterial dis-
ease, rheumatic heart disease, congenital heart disease,
deep vein thrombosis, and pulmonary embolism.17
Patients with PD according to the WHO deﬁnition, ie,
asthma, bronchiectasis, chronic obstructive lung disease
including COPD, bronchitis, and emphysema, chronic
rhinosinusitis, hypersensitivity pneumonitis, lung can-
cer, and neoplasms of respiratory and intrathoracic
organs, lung ﬁbrosis, chronic pleural diseases, pneumo-
coniosis, pulmonary eosinophilia, pulmonary heart dis-
ease and diseases of pulmonary circulation including
pulmonary embolism, pulmonary hypertension, cor
pulmonale, rhinitis, sarcoidosis, and sleep apnea
syndrome.18
Data Sources and Searches
Electronic searches of the databases CENTRAL,
MEDLINE, EMBASE, and CINAHL were undertaken on
December 5, 2016. Identiﬁed studies from preliminary
searches were screened to identify additional search
terms.
The search strategy consisted of a combination of
relevant keywords and MeSH/Thesaurus terms for: (1) LC
test, (2) AC test, and (3) physical ﬁtness. To avoid
excluding any relevant subgroups, evaluation of eligibility
of the studies in terms of the patient population was done
by reviewing the full-text publication. The authors of
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unobtainable studies or studies with missing data were
contacted.
Two authors (R.T.L. and C.K.) independently
screened titles and abstracts and assessed eligible articles
in full-text. Any inconsistencies between authors were
solved by discussion and, if relevant, a third author (L.T.)
was consulted.
Data Extraction
The following information was extracted from in-
cluded studies: sample size, study design, patient popula-
tion (CVD or PD), sex distribution, mean age, mean height,
mean weight, mean body mass index (BMI), highest
obtained VO2 value from AC, highest obtained VO2 value
from LC, mean difference between the highest obtained
VO2 values, correlation between the highest obtained VO2
values from AC and LC, mean peak respiratory exchange
ratio (RER) from AC and from LC, protocol type (ramp/
incremental), starting Watt level on AC and LC, incre-
ments on AC and LC, order of testing, and hours between
testing. The preferred outcome was body mass relative
VO2max reported as mL·kg
21
·min21. However, older
studies tend to report the absolute VO2max instead of the
body mass relative VO2max.
11 Because of this and if
possible, both types of outcome were extracted or
calculated and used in the analyses. Two authors (R.T.L.
and C.K.) independently extracted the above listed data
from all included studies. Any inconsistencies between
authors was discussed and solved with consultation of
a third author (L.T.).
Risk of Bias Assessment
The Quality Assessment Tool for Observational Cohort
and Cross-Sectional Studies19 was used as a template for
assessing the methodological quality of all included
studies. Quality assessment items 5 and 9 to 12 (groups
recruited from the same population, concurrent controls,
exposure assessment priori outcome assessment, exposure
measures and assessment, and blinding of exposure
assessor) were not applicable for the research question in
this review and the items did not contribute to the quality
rating. Each item was assessed for “low risk,” “unclear
risk,” or “high risk” of bias. Two authors (R.T.L. and C.K.)
independently undertook the quality assessment. Any
inconsistencies between authors were solved by discussion
and, if relevant, a third author (L.T.) was consulted. The
risk of bias assessment was performed rigorously according
to the PROSPERO protocol.15
Data Analysis
Two studies included more than one group in the
CPET (men/women or different groups in an RCTAQ:13 ) and
hence did also report values for the speciﬁc groups.12,20
Because of this, the analyses were performed with the
results of the speciﬁc groups. The analyses on respectively
mL·kg21·min21 and L/min were evaluated by 2 random-
effects meta-analyses pooling the mean differences be-
tween the obtained AC values and the obtained LC values.
Second, 2 random-effects meta-analyses pooling the ratios
between the obtained AC values and the obtained LC
values for respectively mL·kg21·min21 and for L/min were
undertaken. The analyses were stratiﬁed on patient
population (CVD or PD).
To perform the analyses of the mean difference of
values reported as mL·kg21·min21 or L/min, the mean
difference was calculated for each study. Positive mean
differences favor the LC as having the largest values. The
SD of this difference was calculated and adjusted for the
within-subject correlation using the method of chapter
16.4.6.1 in the Cochrane Handbook.21 As no studies
reported correlation values, we chose to impute a correla-
tion value of 0.5 as it represents a moderate positive
relationship between the test values, which was described
in the protocol.15
To obtain the values needed for the meta-analysis, the
following calculation was performed for each individual
study. With AC value be denoted as VO2AC, LC value as
VO2LC, the correlation value as r, and the SDs as SDdiff,
SDAC, and SDLC.
Mean difference ¼ VO2LC2VO2AC
SDdiff ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
SD2AC1 SD
2
LC2 ð23 r3 SDAC3 SDLCÞ
q
We calculated the ratio and used the values in a meta-
analysis to express the association between the 2 types of
CPET. The ratio between the maximal obtained VO2 from
AC and from LC was calculated for each study as a ratio of
the mean values.22 Ratios below 1.0 favor the LC as having
the largest values. To AQ:14fully use the values in a meta-
analysis, a logarithmic transformation was needed use and
the re-transformation was done in Stata using the eform
command to get the pooled ratio and 95% conﬁdence
intervals (CIs). For a study reporting the values, let the
ratio be denoted as VO2ratio.
lnðVO2ratioÞ ¼ ln

VO2AC
VO2LC

SE½lnðVO2ratioÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
n
3

SDAC
VO2AC
2
1
1
n
3

SDLC
VO2LC
2s
The levels of statistical heterogeneity were assessed
using the I2 score from each analysis. I2 values from 0% to
25% were interpreted as the meta-analysis having a low
level of heterogeneity, values from 26% to 50% as
a moderate level, values from 51% to 75% as a high level,
and from 76% to 100% as a considerable level.23,24
To avoid excluding studies from the meta-analyses,
missing SDs were imputed from the median covariate-
speciﬁc SD, respectively from CVD studies and PD studies,
according to the Cochrane Handbook.25
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Subgroup analyses were performed by stratiﬁcation on
patient population (CVD or PD). Sensitivity analyses on L/
min outcome were performed. Sensitivity analyses on small
study bias were performed using the Egger test and, if
signiﬁcant, a metatrim analysis was performed to evaluate
small study bias from imprecise studies. Meta-analyses
stratiﬁed on the risk of bias assessmentwere used to evaluate
if any heterogeneity in the analyses of the mean difference
and the ratio was associated with methodological quality
(low risk, unclear risk, or high risk).
Univariate meta-regressions were performed on the
following continuous outcome measures: mean age, mean
BMI (calculated for studies not reporting BMI), sex
distribution (percentage of males), and mean difference in
peak RER values. Size of aerobic capacity (based on the
AstrandAQ:15 classiﬁcation—“low,” “fair,” “average,” “good,” or
“high”)26 was analyzed as a categorical outcome.
All analyses were performed using Stata 14.0 software
(StataCorp, 2013. Stata Statistical Software: Release 14.9;
College Station, TX: StataCorp LP). Flowchart and risk of
bias is presented using Review Manager 5.3 (Cochrane
collaboration) software. A P value# .05 was considered as
statistically signiﬁcant.
RESULTS
Study Inclusion
The electronic searches identiﬁed 4154 records. After
removing 707 duplicates, 3447 studies remained. Screening
title and abstract resulted in exclusion of 3222 studies as
they did notmeet the CPET inclusion criteria, and thus, 225
studies were considered eligible for review in full text. In the
full-text review, 211 studieswere excluded in total; 118were
excluded due to lack of patients with CVD/PD, 25 for not
reporting VO2 values, 46 for lack of AC testing, 7 for lack of
LC testing, 1 for lack of within-comparison design, 1 for lack
of data, and 12 studies were unobtainable in full-text
versions or only available in versions unable to translate
(Persian, Turkish, and Japanese). Thus, 14 studies (pub-
lished between 1971 and 2009) were included in the review.
The study selection process is summarized in½F1 Figure 1.
Characteristics of the 14 included studies (17 groups, 411
participants) are listed in the Appendix, Supplemental
Digital Content 1 (see Table 3, http://links.lww.com/CPTJ/
A2). A summary of the included studies is listed in½T1 Table 1.
Risk of Bias in Included Studies
Risk of bias in included studies is illustrated in detail in
F2 Figure 2.
Mean Difference in Physical Fitness
The random-effects meta-analysis for the mean
difference in mL·kg21·min21 is shown in½F3 Figure 3. A
total of 14 groups from 11 studies (359 participants)
reported data for the mean difference measured in
mL·kg21·min21. The overall mean difference was 3.54
mL·kg21·min21, (95% CI: 2.08, 5.01), I2 5 91.5%,
P , .001, favoring LC. For patients with CVD, a pooled
mean difference of 4.30 mL·kg21·min21, (95% CI: 1.96,
6.65), I2 5 92.6%, P , .001, favoring LC was found. For
patients with PD, a pooled mean difference of 2.25
mL·kg21·min21, (95% CI: 0.57, 3.94), I 5 86.7%,
P , .001, favoring LC was found. According to the
I2 values, the results are likely to be affected by
considerable heterogeneity.
Sensitivity Analysis on Mean Difference
Measured in L/min
Random-effects meta-analysis for the mean differ-
ence in L/min is shown in ½F4Figure 4. All 17 groups from the
14 studies (411 participants) reported data for the mean
difference measured in L/min. The overall mean differ-
ence was 0.25 L/min, (95% CI: 0.13, 0.23), I2 5 92.6%, P
, .001, favoring LC. For patients with CVD, a pooled
mean difference of 0.32 L/min, (95% CI: 0.17, 0.47), I25
94.8%, P, .001, favoring LCwas found. For patients with
PD, a pooled mean difference of 0.18 L/min, (95% CI:
0.13, 0.23), I25 83.7%, P, .001, favoring LC was found.
According to the I2 values, the results are likely to be
affected by considerable heterogeneity.
Fig. 1. Study flow diagram.
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Sensitivity Analysis for Small Study Bias
The Egger test showed a signiﬁcant result (P 5 .030) for
mL·kg21·min21 and anonsigniﬁcant result (P5 .15) for L/min,
suggesting that small study bias is present in the random-effects
meta-analysis of the mean difference in mL·kg21·min21. This
means that the smallest study reports the largest mean
difference. The followingmetatrim analysis adjusted the overall
mean difference to 1.95 mL·kg21·min21, (95% CI: 0.22, 3.68).
Analyses on the Ratios
The random-effects meta-analysis for the ratio is
shown in ½F5Figure 5. A total of 14 groups from 11 studies
(349 participants) reported results in mL·kg21·min21.
The overall ratio was 0.83, (95% CI: 0.77, 0.89), I25 0%,
P 5 .909, favoring LC. For patients with CVD, a pooled
of ratio of 0.83, (95% CI: 0.75, 0.91), I2 5 0%, P 5 .718,
favoring LC was found. For patients with PD, a pooled
TABLE 1
Study Characteristics of the 14 Included StudiesAQ:21
Population
Cardiovascular Disease Pulmonary Disease Combined
N 5 10, n 5 207 N 5 7, n 5 204 N 5 17, n 5 411
Continent of publication, %
North America 62.5 50 57.2
Europe 37.5 33.33 35.7
Australia 0 16.67 7.1
Study design, %
RCT 12.5 0 7.1
Non-RCT 12.5 16.67 14.3
Case-control 25 33.33 28.6
Cross-sectional 50 50 50
Participant characteristics
Gender, %
Male only 60 57.1 47.1
Female only 0 14.3 5.8
Mixed 40 28.6 47.1
Participant characteristics, median (IQR)
Mean age, years 59 (52–66) 62 (61–66.5) 61 (52.25–66.25)
Mean BMI, kg/m2 26.6 (25–28.4) 26 (23.75–26.9) 26.35 (24.75–26.35)
Aerobic capacity, %
Low 75 100 85.7
Average 25 0 14.3
Test characteristics, %
Order on AC/LC test
AC ﬁrst 0 0 0
LC ﬁrst 0 33.37 7.2
Random order 87.5 16.67 71.4
Not reported 12.5 50 21.4
Ramp 0 0 0
Incremental 37.5 33.33 35.7
Different protocol for AC/LC 0 16.67 7.2
Not reported 62.5 50 57.1
Test characteristics, median (IQR)
Time between tests (hours) 24 (12.5–36) 2 (2–24) 24 (2–24)
AC start level (W) 12.5 (9–15.67) 0 (0–5) 9.5 (4.5–15)
LC start levels (W) 15.7 (9–27.26) 0 (0–0) 9 (0–24.46)
AC increase/min (W) 7 (5–7) 10 (5–15) 7 (5–7)
LC increase/min (W) 14 (8.17–14) 15 (10–30) 14 (10–16.34)
Aerobic capacity based on the deﬁnition of Astrand.
AC, arm cycle; BMI, body mass index; IQR, interquartile range; LC, leg cycle; mL·kg21·min21, milliliters per kilogram bodyweight per minute;
N, number of groups; n, number of patients.
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ratio of 0.83, (95% CI: 0.74, 0.92), I2 5 0%, P 5 .827,
favoring LC was found. According to the I2 values, the
results are not likely to be affected by heterogeneity.
Sensitivity Analysis on Results in L/min
The random-effects meta-analysis for the ratio is
shown in½F6 Figure 6. All 17 groups from the 14 studies
(411 participants) reported results in L/min. The overall
ratio was 0.83, (95% CI: 0.78, 0.89), I25 0%, P5 .937. For
patients with CVD, a pooled ratio of 0.84, (95% CI: 0.77,
0.92), I2 5 0%, P 5 .654, favoring LC was found. For
patients with PD a pooled ratio of 0.83, (95% CI: 0.75,
0.92), I2 5 0%, P 5 .959, favoring LC was found.
According to the I2 values, the results are not likely to be
affected by heterogeneity.
Sensitivity Analysis for Small Study Bias
The Egger test showed no signiﬁcant result (P 5 .943
and P 5 .966), respectively, for the ratios of the results in
mL·kg21·min21 and L/min in the random-effects meta-
analyses of the ratios.
Stratified Analysis on Risk of Bias
Figures 5.1–5.8, 6.1–6.8, 7.1–7.2, and 8.1–8.8, found in
the appendix (see Supplemental Digital Content 1, http://
links.lww.com/CPTJ/A2), show stratiﬁed analysis on the risk
of bias.Meandifference resultswere signiﬁcantly different on
the risk of bias evaluation on study population in mL·kg2
1
·min21 (see Fig. 5.2, Supplemental Digital Content 1,
http://links.lww.com/CPTJ/A2), target population in
mL·kg21·min21 (seeFig. 5.3, SupplementalDigital Content
1, http://links.lww.com/CPTJ/A2), prespeciﬁed criteria for
inclusion and exclusion in mL·kg21·min21 (see Fig. 5.5,
Supplemental Digital Content 1, http://links.lww.com/
CPTJ/A2), and patient deﬁnition in mL·kg21·min21 (see
Fig. 5.6, Supplemental Digital Content 1, http://links.lww.
com/CPTJ/A2). The results were also signiﬁcantly different
on study population in L/min (see Fig. 6.2, Supplemental
Digital Content 1, http://links.lww.com/CPTJ/A2), target
population in L/min (see Fig. 6.3, Supplemental Digital
Content 1, http://links.lww.com/CPTJ/A2), sample size
justiﬁcation in L/min (see Fig. 6.4, Supplemental Digital
Content 1, http://links.lww.com/CPTJ/A2), prespeciﬁed
criteria for inclusion and exclusion in L/min (see Fig. 6.5,
Supplemental Digital Content 1, http://links.lww.com/
CPTJ/A2), and patient deﬁnition in L/min (see Fig. 6.6,
Supplemental Digital Content 1, http://links.lww.com/
CPTJ/A2), all with a higher mean difference among the
studies assessed with high risk of bias in the above-
mentioned ﬁgures. No signiﬁcant difference on the ratio
was found on the risk of bias in both outcomes.
Univariate Meta-regressions on the
Mean Difference
Results from univariate meta-regressions are shown
in ½T2Table 2. Not all included studies reported all values for
the groups. Hence, between 5 and 14 groups were
included in the analysis on the mL·kg21·min21 outcome.
Signiﬁcant associations between mean difference in VO2
in mL·kg21·min21 and mean age (coefﬁcient 20.27, P ,
.001), Astrand classiﬁcation (coefﬁcient 5.58, P 5 .027),
and mean aerobic capacity obtained from LC (coefﬁcient
0.39, P , .001) were found. Between 7 and 17 groups
were included in the analysis on the V02 L/min outcome.
Signiﬁcant associations betweenmean difference in L/min
and mean age (coefﬁcient 20.02, P , .001), Astrand
classiﬁcation (coefﬁcient 0.43, P 5 .018), and mean
Fig. 2. Risk of bias summary: review authors’ judgments
about each risk of bias item for each included study.
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aerobic capacity obtained from LC (coefﬁcient 0.38,
P, .001) were found. Adjusted R2 values were above 80%
in the univariate meta-regressions between mean differ-
ence (mL·kg21·min21 and L/min) and mean age and
mean maximum obtained VO2/mean aerobic capacity
obtained from LC. Hence, most of the heterogeneity
found in the meta-analysis on mean difference in mL·kg2
1
·min21 (Fig. 3) and themeta-analysis onmean difference
in L/min (Fig. 4) is explained by mean age and aerobic
capacity.
Univariate Meta-regressions on the Ratios
Results from univariate meta-regressions are shown
in ½T3Table 3. Not all included studies reported values for all
variables for the included groups. Hence, between 5 and
Fig. 3. Random-effects meta-analysis on the mean difference between the arm cycle and the leg cycle reported as mL·kg2
1
·min21, stratified on cardiovascular disease (CVD)/pulmonary disease (PD).AQ:23 CI, confidence interval; COPD, chronic
obstructive pulmonary diseaseAQ:24 .
Fig. 4. Random-effects meta-analysis on the mean difference between the arm cycle and the leg cycle reported as L/min,
stratified on cardiovascular disease (CVD)/pulmonary disease (PD). CI, confidence interval; COPD, chronic obstructive
pulmonary disease.
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14 groups were included in the analysis on the ratio in
mL·kg21·min21. No signiﬁcant associations between the
ratio in mL·kg21·min21 and independent variables were
found. Between 7 and 17 groups were included in the
analysis on ratio of the L/min outcome. Signiﬁcant
associations between the ratio in L/min and mean age
(coefﬁcient 0.01, P5 .047) were found. No R2 values were
present as no heterogeneity was found in the meta-
analyses on the ratio from Figures 5 and 6.
DISCUSSION
This systematic review included results from 17
groups and 411 patients. The overall mean difference
Fig. 5. Random-effects meta-analysis on the ratio between the arm cycle and the leg cycle reported as mL·kg21·min21,
stratified on cardiovascular disease (CVD)/pulmonary disease (PD). CI, confidence interval; COPD, chronic obstructive
pulmonary disease.
Fig. 6. Random-effects meta-analysis on the ratio between the arm cycle and the leg cycle reported as L/min, stratified on
cardiovascular disease (CVD)/pulmonary disease (PD). CI, confidence interval; COPD, chronic obstructive pulmonary disease.
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between AC and LC values was found to be 3.48 mL·kg2
1
·min21, (95% CI: 1.94, 5.03) and the overall ratio was
found to be 0.83 (95% CI: 0.77, 0.90). The mean difference
measured in mL·kg21·min21 was signiﬁcantly associated
with age and aerobic capacity, meaning that studies with
older patients, and lower aerobic capacity, reported a smaller
mean difference. The ratio of the results in L/min was
signiﬁcantly associated with age, meaning that studies with
older patients reported a larger ratio between the test values.
Themeta-analyses on themean difference inmL·kg21·min2
1 (Fig. 3) and L/min (Fig. 4) indicate that the mean
differences were similar when comparing patients with
CVD to patients with PD. The main ﬁnding of the meta-
analyses on the ratios of the results in mL·kg21·min21
TABLE 2
Univariate Meta-Regressions on Mean Difference Between Arm Cycle Values and Leg Cycle ValuesAQ:22
Independent Variable, mL·kg21·min21 N Mean Coefﬁcient (95% CI) P Adjusted R2, %
Mean age 14 20.27 (20.35, 20.19) ,.001 91.60
Mean BMI 11 20.72 (22.72, 1.27) .433 23.52
Sex distribution 14 0.029 (20.059, 0.12) .484 24.28
Diff RER 5 276.10 (2413.40, 261.20) .558 220.46
Astrand 14 5.68 (0.84, 10.54) .025 33.71
Mean aerobic capacity obtained from LC 14 0.39 (0.30, 0.48) ,.001 97.66
Independent Variable, L/min N Mean Coefﬁcient (95% CI) P Adjusted R2, %
Mean age 17 20.021 (20.027, 20.015) ,.001 83.96
Mean BMI 12 20.038 (20.17, 0.094) .529 26.14
Sex distribution 17 0.0019 (20.004, 0.008) .521 24.32
Diff RER 7 21.33 (220.50, 17.8) .865 225.20
Astrand 17 0.43 (0.085, 0.78) .018 31.93
Mean VO2max obtained from LC 17 0.38 (0.30, 0.46) ,.001 94.39
Astrand: Astrand classiﬁcation of aerobic capacity as categorical outcome (low/average).
BMI, body mass index; CI, conﬁdence interval; diff RER, difference in respiratory exchange ratio (positive values favors leg cycle); mL·kg2
1
·min21, milliliters per kilogram bodyweight per minute; N, number of groups included in the analysis; LC, leg cycle.
TABLE 3
Univariate Meta-Regressions on the Ratio Between Arm Cycle Values and Leg Cycle Values
Independent Variable, mL·kg21·min2
1 N Mean Coefﬁcient (95% CI) P Adjusted R2, %
Mean age 14 0.01 (20.0004, 0.013) .064 0
Mean BMI 11 0.027 (20.048, 0.103) .437 0
Sex distribution 14 20.0004 (20.0032, 0.0025) .790 0
Diff RER 5 0.94 (217.72, 19.6) .883 0
Astrand 14 20.081 (20.28, 0.121) .398 0
Mean aerobic capacity obtained from LC 14 20.01 (20.0176, 0.0018) .101 0
Independent Variable, L/min N Mean Coefﬁcient (95% CI) P Adjusted R2, %
Mean age 17 0.01 (0.0001, 0.012) .047 0
Mean BMI 12 0.022 (20.034, 0.078) .402 0
Sex distribution 17 20.0002 (20.003, 0.0025) .881 0
Diff RER 7 20.122 (213.65, 13.89) .983 0
Astrand 17 20.089 (20.27, 0.096) .321 0
Mean VO2max obtained from LC 17 20.1 (20.211, 0.0031) .056 0
Astrand: Astrand classiﬁcation of aerobic capacity as categorical outcome (low/average).
BMI, body mass index; CI, conﬁdence interval; diff RER, difference in respiratory exchange ratio (positive values favors leg cycle); LC, leg cycle;
mL·kg21·min21, milliliters per kilogram bodyweight per minute; N, number of groups included in the analysis.
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(Fig. 5) and in L/min (Fig. 6) indicates that the ratio of
0.83 is similar when comparing patients with CVD to
patients with PD.
The sensitivity analysis and investigation for small
study bias on mean difference in mL·kg21·min21 (Fig. 3)
indicate that the smallest study reports the largest mean
difference. The metatrim analysis adjusted the mean
difference for small study bias and imputed 3 ﬁctive studies
with mean differences favoring the AC. Although part of an
appropriate analysis rationale, this imputation seems
irrelevant as neither of our results nor previous ﬁndings in
healthy adults11 did indicate that groups of participants
would obtain largermean aerobic capacity fromAC.Hereby,
the most important information from this sensitivity
analysis is that the smallest study is inﬂuencing the pooled
mean difference toward a larger estimate.
The I2 values from the analyses on the mean difference
indicate considerable heterogeneity between the study
results, whereas the I2 values from the analyses on the ratios
indicate no heterogeneity. The considerable heterogeneity
found can be explained by the narrow CIs seen in Figures 3
and 4 and the nonexisting heterogeneity can be explained by
the overlapping CIs seen in Figures 5 and 6.27 The
considerable heterogeneity found in the analyses on the
mean difference is evaluated in the univariate meta-
regressions from Table 2. The results show that the mean
difference decreases with higher age and increases with
higher aerobic capacity. The correlation is most likely
explained in the association between age and aerobic capacity
ﬁrst described by Astrand;26 thus, older patients will have
lower aerobic capacity and lower mean difference between
AC and LC. In general, the considerable heterogeneity and
diversity in the results of the meta-analyses of the mean
difference are explained mostly on the level of aerobic
capacity (R2 value above 90%). The univariate meta-
regressions with negative adjusted R2 values, presented in
Table 2, describe the mean difference poorly and thus, BMI,
sex distribution, and difference in RER values cannot be not
be used to explain the heterogeneity in the results. A
signiﬁcant positive association between the ratio of the results
in L/min and mean age were found in Table 3 (P 5 .047);
hence, older patients will have AC values closer to LC values,
comparedwith younger patients. The results fromTable 3 are
affected by the wide CIs found in the analyses on the ratios.
As no heterogeneity was found in Figures 5 and 6, no R2
could be calculated in Table 3. However, the explanation of
the association between the ratio and age is probably also
found in the previously described correlation between
aerobic capacity and age.26
The included study of MacDonald et al28 included
borderline hypertensive patients and reported a higher
physical ﬁtness than the other studies. It could be argued
that the included patients are only borderline CVD
patients.28 Four sensitivity analyses without the study were
performed and in general the overall mean difference
decreased and the overall ratio decreased. The results of
the mean difference without MacDonald et al were 2.65
mL·kg21·min21 (95% CI: 1.62, 3.68) and 0.19 L/min, (95%
CI: 0.15, 0.23),whichwere smaller than themean differences
from the main analyses. The ratio of the results measured in
mL·kg21·min21withoutMacDonald et al were 0.84 (95%CI:
0.78, 0.90) and 0.85 of the results in L/min, (95% CI: 0.79,
0.90), which were larger than the ones from the main
analyses on the ratio. However, this does not change our
conclusion, but highlights that groups of patients with
higher physical ﬁtness will have a greater difference between
values from AC and LC. On the other side, the CIs on the
ratio reported from each individual study in Figures 5 and 6
show that some individual patients with either PD or CVD
will achieve a higher VO2 value on AC, compared with the
corresponding value on LC. The values reported in this
article are on group level and it is expected that some
individual patients will differ from the mean results.
Our results have some limitations as the main type of
included studies was observational (prospective and retro-
spective) (according to Table 1). Such study designs lack any
form of preplanned control to account for variables that may
affect the results. None of the included articles described
a random selection of patients and the possibility of selection
bias is present. The risk of bias assessment also highlights the
poor description of the target population, justiﬁcation of
sample size, and description of the statistical methods in the
included studies. Especially, the study published by Martin
et al14 was assessed with high or unclear risk of bias in all of
the items except the research question. According to the
meta-analysis on the mean difference, the study by Martin
et al14 also reports the second highestmean difference in all of
the included articles. However, except the above-mentioned
study, we were not able to conclude whether risk of bias
systematically affected our results toward an overestimation
or underestimation of the mean difference or ratio. Another
limitation is low generalizability to female patients because
most of the included articles were performed on males or on
mixed populations. The study by Carter et al12 was the only
study with a group of only female patients. However, the
univariate meta-regressions on sex distribution do not
indicate any affect by age on the mean difference nor on
the ratio. Seven studies (with 7 groups) reported RER
values.14,29-34 Age-speciﬁc cuts for RER values are often used
to determine whether the VO2 outcome can be categorized as
a maximum value.35 Two of the 7 groups did not meet the
age-speciﬁc criteria for maximal testing32,33 and 4 of the 7
groups did meet the age-speciﬁc criteria.14,29-31,34 However,
it did not seem to affect the results of the mean difference
nor the ratio whether the RER criteria was met or not, but it
should be stated that the VO2 values from the studies of
Owens et al and Franssen et al cannot be categorized as
maximum values.32,33,35
CLINICAL IMPLICATIONS
Implication of AC in testing of patients with CVD is
high and it is already commonly used.1 Arm cycling is
often used in patients with coronary artery disease due to
exercise-induced claudication in LC testing.1 Our results
show that patients with CVD as well as patients with PD
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will obtain a more similar measure of physical ﬁtness on
the 2 exercise tests compared with healthy adults.11 It is
unknown whether the larger ratio between AC and LC
among patients compared with healthy adults11 is caused
by patients being unable to reach the maximal aerobic
capacity on LC, due to atrophy of the legs after inactivity
or central limitations, or that the exercise-induced pain
and discomfort is less on AC compared with LC. The
results presented in this article support the implication
of using AC in patients with CVD. Although the primary
method of using CPET in patients with COPD is on the
treadmill or with LC,2 our results support using AC as an
alternative for CPET. Whether these results can be used
on other patient populations is unknown. However, it
could be hypothesized that patients with central
limitations such as CVD and PD will appear with the
same results. New research should focus on mean
difference and ratio and how the relationships between
AC and LC values are affected by disease severity and
also what exercise testing modality individual patients
prefer.
The pooled ratio of 0.83 is larger than the ratio of 0.7
previously reported for healthy adults,11 suggesting that
differences between AC and LC are smaller in patient
populations. The ratio between AC and LC is only
signiﬁcantly associated with age and thus, the ratio can be
used in a clinical setting throughout an exercise program
where patients are expected to enhance aerobic capacity.
Furthermore, the pooled mean difference of 3.5 mL·kg2
1
·min21 is smaller than the mean difference on 12.5
mL·kg21·min21 previously reported for healthy adults.11
In conclusion, the results in this article show that patients
with a low physical ﬁtness will obtain more similar values
on AC versus LC compared with patients with a higher
physical ﬁtness or healthy adults.11 When the physical
ﬁtness and aerobic capacity is low among patients, the
mean difference between test values from the AC and
from the LC will also be low and the ratio between the
tests will be large.
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